Sur, D., Havasi, A., Lungulescu, C., Volovat, S., Burz, C., & Irimie, A. (2022). Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review. Medicine and Pharmacy Reports. https://doi.org/10.15386/mpr-2120